Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer

被引:60
作者
Launonen, I-M [1 ]
Lyytikainen, N. [1 ]
Casado, J. [1 ]
Anttila, E. A. [1 ]
Szabo, A. [1 ]
Haltia, U-M [1 ,2 ]
Jacobson, C. A. [3 ]
Lin, J. R. [3 ]
Maliga, Z. [3 ]
Howitt, B. E. [4 ]
Strickland, K. C. [5 ]
Santagata, S. [3 ,6 ,9 ]
Elias, K. [7 ,8 ]
D'Andrea, A. D. [8 ]
Konstantinopoulos, P. A. [8 ]
Sorger, P. K. [3 ,9 ]
Farkkila, A. [1 ,2 ,3 ,8 ,10 ]
机构
[1] Univ Helsinki, Res Program Syst Oncol, Helsinki, Finland
[2] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland
[3] Harvard Med Sch, Lab Syst Pharmacol, Boston, MA 02115 USA
[4] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
[5] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
[6] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[7] Brigham & Womens Hosp, Dept Obstet & Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA
[8] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Boston, MA 02115 USA
[9] Harvard Med Sch, Ludwig Ctr Canc Res Harvard, Boston, MA 02115 USA
[10] iCAN Digital Precis Canc Med Flagship, Helsinki, Finland
基金
芬兰科学院;
关键词
T-CELLS; CHEMORESISTANCE; PROLIFERATION; CARCINOMA; COHORT; STROMA;
D O I
10.1038/s41467-022-28389-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The tumour microenvironment has not been fully characterised in high-grade serous ovarian cancers (HGSOC). Here, the authors use highly multiplexed imaging to analyse the HGSOC immune microenvironment at spatial and single-cell resolution, with clinically relevant findings for BRCA1/2-mutated tumours. The majority of high-grade serous ovarian cancers (HGSCs) are deficient in homologous recombination (HR) DNA repair, most commonly due to mutations or hypermethylation of the BRCA1/2 genes. We aimed to discover how BRCA1/2 mutations shape the cellular phenotypes and spatial interactions of the tumor microenvironment. Using a highly multiplex immunofluorescence and image analysis we generate spatial proteomic data for 21 markers in 124,623 single cells from 112 tumor cores originating from 31 tumors with BRCA1/2 mutation (BRCA1/2mut), and from 13 tumors without alterations in HR genes. We identify a phenotypically distinct tumor microenvironment in the BRCA1/2mut tumors with evidence of increased immunosurveillance. Importantly, we report a prognostic role of a proliferative tumor-cell subpopulation, which associates with enhanced spatial tumor-immune interactions by CD8+ and CD4 + T-cells in the BRCA1/2mut tumors. The single-cell spatial landscapes indicate distinct patterns of spatial immunosurveillance with the potential to improve immunotherapeutic strategies and patient stratification in HGSC.
引用
收藏
页数:14
相关论文
共 31 条
[1]   Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer [J].
Ahmed, N. ;
Abubaker, K. ;
Findlay, J. ;
Quinn, M. .
CURRENT CANCER DRUG TARGETS, 2010, 10 (03) :268-278
[2]   Ki-67 as an independent prognostic factor in an unselected cohort of patients with ovarian cancer: Results of an explorative, retrospective study [J].
Battista, Marco Johannes ;
Mantai, Nina ;
Sicking, Isabel ;
Cotarelo, Cristina ;
Weyer, Veronika ;
Lebrecht, Antje ;
Solbach, Christine ;
Schmidt, Marcus .
ONCOLOGY REPORTS, 2014, 31 (05) :2213-2219
[3]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[4]   Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer [J].
Bouberhan, Sara ;
Philp, Lauren ;
Hill, Sarah ;
Al-Alem, Linah F. ;
Rueda, Bo .
CANCERS, 2020, 12 (05)
[5]   Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer [J].
Cardenas, Horacio ;
Jiang, Guanglong ;
Pepin, Jessica Thomes ;
Parker, J. Brandon ;
Condello, Salvatore ;
Nephew, Kenneth P. ;
Nakshatri, Harikrishna ;
Chakravarti, Debabrata ;
Liu, Yunlong ;
Matei, Daniela .
NPJ PRECISION ONCOLOGY, 2019, 3 (1)
[6]   Agile workflow for interactive analysis of mass cytometry data [J].
Casado, Julia ;
Lehtonen, Oskari ;
Rantanen, Ville ;
Kaipio, Katja ;
Pasquini, Luca ;
Hakkinen, Antti ;
Petrucci, Elenora ;
Hynninen, Johanna ;
Hietanen, Sakari ;
Carpen, Olli ;
Biffoni, Mauro ;
Farkkila, Anniina ;
Hautaniemi, Sampsa .
BIOINFORMATICS, 2021, 37 (09) :1263-1268
[7]   The prognostic value of Ki67 in ovarian high-grade serous carcinoma: an 11-year cohort study of Chinese patients [J].
Chen, Ming ;
Yao, Shuzhong ;
Cao, Qinghua ;
Xia, Meng ;
Liu, Junxiu ;
He, Mian .
ONCOTARGET, 2017, 8 (64) :107877-107885
[8]   Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss [J].
Clarke, Blaise ;
Tinker, Anna V. ;
Lee, Cheng-Han ;
Subramanian, Subbaya ;
van de Rijn, Matt ;
Turbin, Dmitry ;
Kalloger, Steve ;
Han, Guangming ;
Ceballos, Kathy ;
Cadungog, Mark G. ;
Huntsman, David G. ;
Coukos, George ;
Gilks, C. Blake .
MODERN PATHOLOGY, 2009, 22 (03) :393-402
[9]   Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer [J].
Desbois, Melanie ;
Udyavar, Akshata R. ;
Ryner, Lisa ;
Kozlowski, Cleopatra ;
Guan, Yinghui ;
Duerrbaum, Milena ;
Lu, Shan ;
Fortin, Jean-Philippe ;
Koeppen, Hartmut ;
Ziai, James ;
Chang, Ching-Wei ;
Keerthivasan, Shilpa ;
Plante, Marie ;
Bourgon, Richard ;
Bais, Carlos ;
Hegde, Priti ;
Daemen, Anneleen ;
Turley, Shannon ;
Wang, Yulei .
NATURE COMMUNICATIONS, 2020, 11 (01)
[10]   Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer [J].
Farkkila, Anniina ;
Gulhan, Doga C. ;
Casado, Julia ;
Jacobson, Connor A. ;
Nguyen, Huy ;
Kochupurakkal, Bose ;
Maliga, Zoltan ;
Yapp, Clarence ;
Chen, Yu-An ;
Schapiro, Denis ;
Zhou, Yinghui ;
Graham, Julie R. ;
Dezube, Bruce J. ;
Munster, Pamela ;
Santagata, Sandro ;
Garcia, Elizabeth ;
Rodig, Scott ;
Lako, Ana ;
Chowdhury, Dipanjan ;
Shapiro, Geoffrey, I ;
Matulonis, Ursula A. ;
Park, Peter J. ;
Hautaniemi, Sampsa ;
Sorger, Peter K. ;
Swisher, Elizabeth M. ;
D'Andrea, Alan D. ;
Konstantinopoulos, Panagiotis A. .
NATURE COMMUNICATIONS, 2020, 11 (01)